These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8736427)

  • 1. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate.
    Michel MC; Grübbel B; Taguchi K; Verfürth F; Otto T; Kröpfl D
    J Auton Pharmacol; 1996 Feb; 16(1):21-8. PubMed ID: 8736427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.
    Büscher R; Heeks C; Taguchi K; Michel MC
    Br J Pharmacol; 1996 Feb; 117(4):703-11. PubMed ID: 8646417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.
    Kenny BA; Naylor AM; Greengrass PM; Russell MJ; Friend SJ; Read AM; Wyllie MG
    Br J Pharmacol; 1994 Apr; 111(4):1003-8. PubMed ID: 7913370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.
    Sato S; Hatanaka T; Yuyama H; Ukai M; Noguchi Y; Ohtake A; Taguchi K; Sasamata M; Miyata K
    Biol Pharm Bull; 2012; 35(1):72-7. PubMed ID: 22223340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 1-adrenoceptor subtype affinities of drugs for the treatment of prostatic hypertrophy. Evidence for heterogeneity of chloroethylclonidine-resistant rat renal alpha 1-adrenoceptor.
    Michel MC; Büscher R; Kerker J; Kraneis H; Erdbrügger W; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):385-95. PubMed ID: 7506392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological properties of naftopidil, a drug for treatment of the bladder outlet obstruction for patients with benign prostatic hyperplasia].
    Ikegaki I
    Nihon Yakurigaku Zasshi; 2000 Aug; 116(2):63-9. PubMed ID: 10976457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of SB 216469, an antagonist which discriminates between the alpha 1A-adrenoceptor and the human prostatic alpha 1-adrenoceptor.
    Chess-Williams R; Chapple CR; Verfurth F; Noble AJ; Couldwell CJ; Michel MC
    Br J Pharmacol; 1996 Nov; 119(6):1093-100. PubMed ID: 8937710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of alpha 1-adrenoceptor subtype selectivity by [3H]-prazosin displacement studies in guinea-pig cerebral cortex and rat spleen membranes.
    Veenstra DM; van Buuren KJ; Nijkamp FP
    Br J Pharmacol; 1992 Sep; 107(1):202-6. PubMed ID: 1358383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
    Maruyama K; Fukutomi J; Chiba T; Yamaguchi M; Takeda M; Hattori K; Nagatomo T
    Gen Pharmacol; 1996 Dec; 27(8):1377-81. PubMed ID: 9304410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cloned and pharmacologically defined rat tissue alpha 1-adrenoceptor subtypes.
    Michel MC; Insel PA
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):136-42. PubMed ID: 7990970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Kubota Y; Imura M; Oda N; Kiniwa M; Hayashi Y; Kohri K
    J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of alpha 1-adrenoceptor subtypes in the human prostatic urethra.
    Taniguchi N; Ukai Y; Tanaka T; Yano J; Kimura K; Moriyama N; Kawabe K
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):412-6. PubMed ID: 9089674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy.
    Yamada S; Suzuki M; Kato Y; Kimura R; Mori R; Matsumoto K; Maruyama M; Kawabe K
    Life Sci; 1992; 50(2):127-35. PubMed ID: 1370569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.
    Martin DJ; Lluel P; Guillot E; Coste A; Jammes D; Angel I
    J Pharmacol Exp Ther; 1997 Jul; 282(1):228-35. PubMed ID: 9223558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.
    Yamada S; Kato Y; Okura T; Kagawa Y; Kawabe K
    Biol Pharm Bull; 2007 Jul; 30(7):1237-41. PubMed ID: 17603160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Djavan B; Marberger M
    Eur Urol; 1999; 36(1):1-13. PubMed ID: 10364649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
    Kenny BA; Naylor AM; Carter AJ; Read AM; Greengrass PM; Wyllie MG
    Urology; 1994 Jul; 44(1):52-7. PubMed ID: 7913781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 1-adrenoceptors in human prostate: characterization and binding characteristics of alpha 1-antagonists.
    Yamada S; Tanaka C; Kimura R; Kawabe K
    Life Sci; 1994; 54(24):1845-54. PubMed ID: 7515140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.
    Taguchi K; Saitoh M; Sato S; Asano M; Michel MC
    J Pharmacol Exp Ther; 1997 Jan; 280(1):1-5. PubMed ID: 8996174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.